84
Participants
Start Date
May 24, 2024
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2029
Fruquintinib
A treatment cycle of 4 weeks, with 5 mg orally once daily for 3 weeks, followed by a 1-week break
Fluorouracil
2.8 g/m² (400mg bolus + 2.4g/m² continuous infusion) given every 2 weeks through hepatic arterial infusion
Oxaliplatin
85 mg/m² given every 2 weeks through hepatic arterial infusion
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
Sun Yat-sen University
OTHER